CD274 and non-small cell lung carcinoma: In the neoadjuvant space, blockade of the PD-1/PD-L1 immune checkpoint combined with preoperative chemotherapy is also a new standard of care for patients with stages IB-IIIA NSCLC regardless of PD-L1 expression6–8.